Add a Calcium Channel Blocker (CCB) as the Third Agent
For patients already on losartan and hydrochlorothiazide who need additional blood pressure control, a calcium channel blocker—specifically a dihydropyridine such as amlodipine—should be added as the third-line agent. 1
Rationale for CCB Addition
The 2020 International Society of Hypertension guidelines provide clear algorithmic guidance for patients on ARB/diuretic combinations who require additional therapy. The recommended progression is:
- Step 1: Low-dose ARB (losartan) + thiazide diuretic (hydrochlorothiazide)
- Step 2: Increase to full doses
- Step 3: Add dihydropyridine CCB 1
This triple combination (ARB + thiazide diuretic + CCB) represents the most evidence-based approach and is consistently recommended across multiple international guidelines 2, 3, 4, 5.
Specific CCB Recommendations
Amlodipine is the preferred dihydropyridine CCB due to:
- Once-daily dosing that improves adherence
- Extensive evidence base in combination therapy
- Complementary mechanism of action to ARBs and diuretics 2, 6
Starting dose: Amlodipine 5 mg once daily, which can be titrated to 10 mg daily if needed 7.
Why CCB Before Other Options
The guidelines explicitly favor CCB addition over other classes because:
- Complementary mechanisms: CCBs block compensatory vasoconstriction that may limit ARB/diuretic effectiveness 4
- Proven efficacy: The ARB + diuretic + CCB combination has the strongest evidence for cardiovascular risk reduction 2, 3
- Safety profile: This combination avoids the risks of dual RAAS blockade (combining ACE inhibitor with ARB, which is contraindicated) 8, 9, 4
Fourth-Line Options (If Triple Therapy Fails)
Only after maximizing the ARB + diuretic + CCB combination should you consider:
- Spironolactone 12.5-25 mg daily (preferred fourth agent) 1
- Alternatives if spironolactone contraindicated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker 1
Monitor serum potassium and renal function closely when adding spironolactone to an ARB/diuretic regimen, as hyperkalemia risk increases 9.
Critical Contraindications
Never combine losartan with an ACE inhibitor or another ARB—this dual RAAS blockade increases cardiovascular and renal risk without additional benefit 4, 5. The ONTARGET trial definitively showed harm from this combination 3.
Practical Implementation
- Ensure losartan and hydrochlorothiazide are at adequate doses (losartan 100 mg, HCTZ 25 mg) before adding third agent 10
- Add amlodipine 5 mg once daily
- Reassess blood pressure in 2-4 weeks 1, 3
- Titrate amlodipine to 10 mg if BP target not achieved
- Consider single-pill combinations to improve adherence 3, 5
Common Pitfall
The most common error is adding a beta-blocker or ACE inhibitor before trying a CCB. Beta-blockers are less effective for stroke prevention 5, and ACE inhibitors combined with ARBs are contraindicated 4. Stick to the evidence-based sequence: ARB + diuretic → add CCB → add spironolactone.